RNXT RenovoRx, Inc.
Price Chart
Executive Summary
Mark Voll, newly appointed CFO of RenovoRx, filed an amended Form 3/A to correct his title after previously misstating it as CEO. The filing reflects ownership of 25,000 shares acquired in the open market prior to his appointment. No new share transactions or material financial information were disclosed.
Actionable Insight
No trading action warranted. Monitor future insider transactions and upcoming earnings or clinical trial updates for material developments.
Key Facts
- Mark Voll filed Form 3/A to correct his title from CEO to CFO on the original Form 3 filing.
- He holds 25,000 shares of RNXT common stock, purchased in the open market before becoming CFO.
- No new share purchases, sales, or grants were reported in this amendment.
- The correction was administrative, with no indication of misconduct or financial implications.
Financial Impact
No financial impact — this is a clerical correction with no change in share ownership or capital structure.
Risk Factors
- Minimal reputational risk from initial misfiling, though promptly corrected.
- Low liquidity risk given RNXT's small market cap ($43M), but no direct link to this filing.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3/A Filing (Primary) | 0001493152-26-013082 |
| Document: 0001493152-26-013082-index.html | 0001493152-26-013082 |
| Document: 0001493152-26-013082.txt | 0001493152-26-013082 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
1d ago
|
Press Release
| $0.7861 awaiting T+5 | awaiting T+5 | — | $0.8101 (+3.05%) |
|
May 15, 2026
5d ago
|
10-K/A
| — | awaiting T+5 | — | — |
|
May 14, 2026
6d ago
|
8-K
| $0.8561 awaiting T+5 | awaiting T+5 | — | $0.8101 (−5.37%) |
|
Apr 29, 2026
21d ago
|
Press Release
| $0.8310 $0.9280 | ▲ +11.67% | ▲ +8.56% | $0.8101 (−2.52%) |
|
Apr 28, 2026
22d ago
|
EFFECT
| — | awaiting T+5 | — | — |
|
Apr 16, 2026
4w ago
|
S-3
| $1.00 $0.8570 | ▼ −14.30% | ▼ −14.85% | $0.8101 (−18.99%) |
|
Apr 14, 2026
5w ago
|
Press Release
| $1.03 $0.9490 | ▼ −7.86% | ▼ −9.26% | $0.8101 (−21.35%) |
|
Mar 30, 2026
7w ago
|
8-K
| $1.01 $0.9390 | ▼ −7.03% | ▼ −10.97% | $0.8101 (−19.79%) |
|
Mar 30, 2026
7w ago
|
Press Release
| $1.01 $0.9390 | ▼ −7.03% | ▼ −10.97% | $0.8101 (−19.79%) |
|
Mar 27, 2026
7w ago
|
3/A
| $1.13 $0.9320 | ▼ −17.52% | ▼ −21.38% | $0.8101 (−28.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access